Randgold Resources: Holding(s) in Company JERSEY, CHANNEL

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
496
Randgold Resources: Holding(s) in Company

JERSEY, CHANNEL ISLANDS--(Marketwired - Nov 1, 2017) - Randgold Resources (NASDAQ: GOLD)

RANDGOLD RESOURCES LIMITED Incorporated in Jersey, Channel Islands Reg. No. 62686 LSE Trading Symbol: RRS NASDAQ Trading Symbol: GOLD ("Randgold Resources" or the "Company")

Jersey, Channel Islands, 1 November 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Randgold Resources Limited
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)  
Non-UK issuer   X
2. Reason for the notification (please mark the appropriate box or boxes with an "X")  
An acquisition or disposal of voting rights    
An acquisition or disposal of financial instruments   X
An event changing the breakdown of voting rights    
Other (please specify) iii :    
3. Details of person subject to the notification obligation iv
Name BlackRock, Inc.
City and country of registered office (if applicable) Wilmington, DE, USA
4. Full name of shareholder(s) (if different from 3.) v
Name  
City and country of registered office (if applicable)  
5. Date on which the threshold was crossed or reached vi : 31/10/2017
6. Date on which issuer notified (DD/MM/YYYY): 01/11/2017
7. Total positions of person(s) subject to the notification obligation
  % of voting rights attached to shares (total of 8. A)   % of voting rights through financial instruments (total of 8.B 1 + 8.B 2)   Total of both in % (8.A + 8.B)   Total number of voting rights of issuer vii
Resulting situation on the date on which threshold was crossed or reached 7.25%   9.74%   16.99%   94,073,286
Position of previous notification (if applicable) 7.33%   10.02%   17.36%    
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of shares   Number of voting rights ix   % of voting rights
ISIN code (if possible)   Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)   Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)   Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)   Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB00B01C3S32       6,821,218       7.25%
                 
                 
SUBTOTAL 8. A   6,821,218   7.25%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument   Expiration date x   Exercise/ Conversion Period xi   Number of voting rights that may be acquired if the instrument is exercised/converted.   % of voting rights
Securities Lending           44,259   0.04%
American Depository Receipt           9,050,754   9.62%
                 
        SUBTOTAL 8. B 1   9,095,013   9.66%
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument   Expiration date x   Exercise/ Conversion Period xi   Physical or cash settlement xii   Number of voting rights   % of voting rights
CFD           Cash   71,932   0.07%
                     
                     
            SUBTOTAL 8.B.2   71,932   0.07%
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii  
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity xiv (please add additional rows as necessary) X
Name xv   % of voting rights if it equals or is higher than the notifiable threshold   % of voting rights through financial instruments if it equals or is higher than the notifiable threshold   Total of both if it equals or is higher than the notifiable threshold
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock Holdco 4, LLC            
BlackRock Holdco 6, LLC            
BlackRock Delaware Holdings Inc.            
BlackRock Fund Advisors            
BlackRock Institutional Trust Company, National Association            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock Holdco 3, LLC            
BlackRock Canada Holdings LP            
BlackRock Canada Holdings ULC            
BlackRock Asset Management Canada Limited            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock Group Limited            
BlackRock Investment Management (UK) Limited   1.88%   8.76%   10.65%
             
BlackRock, Inc.            
Trident Merger, LLC            
BlackRock Investment Management, LLC            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock Holdco 4, LLC            
BlackRock Holdco 6, LLC            
BlackRock Delaware Holdings Inc.            
BlackRock Fund Advisors            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock Australia Holdco Pty. Ltd.            
BlackRock Investment Management (Australia) Limited            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock (Singapore) Holdco Pte. Ltd.            
BlackRock Asia-Pac Holdco, LLC            
BlackRock HK Holdco Limited            
BlackRock Cayco Limited            
BlackRock Trident Holding Company Limited            
BlackRock Japan Holdings GK            
BlackRock Japan Co., Ltd.            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock Group Limited            
BlackRock Advisors (UK) Limited            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock (Singapore) Holdco Pte. Ltd.            
BlackRock Asia-Pac Holdco, LLC            
BlackRock HK Holdco Limited            
BlackRock Asset Management North Asia Limited            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock (Singapore) Holdco Pte. Ltd.            
BlackRock (Singapore) Limited            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock Group Limited            
BlackRock Investment Management (UK) Limited            
BlackRock Asset Management Deutschland AG            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock Group Limited            
BlackRock (Netherlands) B.V.            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock Capital Holdings, Inc.            
BlackRock Advisors, LLC            
             
BlackRock, Inc.            
BlackRock Holdco 2, Inc.            
BlackRock Financial Management, Inc.            
BlackRock International Holdings, Inc.            
BR Jersey International Holdings L.P.            
BlackRock Group Limited            
BlackRock International Limited            
             
10. In case of proxy voting, please identify:
Name of the proxy holder  
The number and % of voting rights held  
The date until which the voting rights will be held  
11. Additional information xvi
BlackRock Regulatory Threshold Reporting Team
Jana Blumenstein
020 7743 3650
Place of completion 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
Date of completion 1 November, 2017

RANDGOLD RESOURCES ENQUIRIES:

Chief Executive Mark Bristow +44 788 071 1386 +44 779 775 2288   Financial Director Graham Shuttleworth +44 1534 735 333 +44 779 771 1338   Investor & Media Relations Kathy du Plessis +44 20 7557 7738 Email: randgold@dpapr.com
         

Contact: RNS Customer Services 0044-207797-4400 rns@londonstockexchange.com http://www.rns.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading